Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Like
Tweet
Print
Michael L. Kyle, MD
SVP CMO
Currax Pharmaceuticals
Poster(s):
(168) Evaluating the Cardiovascular Safety of Naltrexone/Bupropion in the United States
Monday, August 26, 2024
8:00 AM – 6:00 PM
CEST